1. Home
  2. RLMD vs STAK Comparison

RLMD vs STAK Comparison

Compare RLMD & STAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • STAK
  • Stock Information
  • Founded
  • RLMD 2004
  • STAK 2020
  • Country
  • RLMD United States
  • STAK China
  • Employees
  • RLMD N/A
  • STAK N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • STAK
  • Sector
  • RLMD Health Care
  • STAK
  • Exchange
  • RLMD Nasdaq
  • STAK NYSE
  • Market Cap
  • RLMD 20.3M
  • STAK 22.7M
  • IPO Year
  • RLMD N/A
  • STAK 2025
  • Fundamental
  • Price
  • RLMD $0.64
  • STAK $1.79
  • Analyst Decision
  • RLMD Buy
  • STAK
  • Analyst Count
  • RLMD 3
  • STAK 0
  • Target Price
  • RLMD $5.00
  • STAK N/A
  • AVG Volume (30 Days)
  • RLMD 211.8K
  • STAK 598.1K
  • Earning Date
  • RLMD 08-11-2025
  • STAK 01-01-0001
  • Dividend Yield
  • RLMD N/A
  • STAK N/A
  • EPS Growth
  • RLMD N/A
  • STAK 6.02
  • EPS
  • RLMD N/A
  • STAK 0.28
  • Revenue
  • RLMD N/A
  • STAK $22,248,609.00
  • Revenue This Year
  • RLMD N/A
  • STAK N/A
  • Revenue Next Year
  • RLMD N/A
  • STAK N/A
  • P/E Ratio
  • RLMD N/A
  • STAK $5.93
  • Revenue Growth
  • RLMD N/A
  • STAK N/A
  • 52 Week Low
  • RLMD $0.24
  • STAK $1.13
  • 52 Week High
  • RLMD $4.02
  • STAK $4.53
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 50.91
  • STAK N/A
  • Support Level
  • RLMD $0.60
  • STAK N/A
  • Resistance Level
  • RLMD $0.74
  • STAK N/A
  • Average True Range (ATR)
  • RLMD 0.06
  • STAK 0.00
  • MACD
  • RLMD 0.00
  • STAK 0.00
  • Stochastic Oscillator
  • RLMD 44.19
  • STAK 0.00

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About STAK STAK INC.

Stak Inc is engaged in research, development, manufacturing, and sale of oilfield-specialized production and maintenance equipment. It design and manufacture oilfield-specialized production and maintenance equipment and also sell oilfield-specialized production and maintenance equipment components, related products, and provide automation solutions. Its products include oilfield vehicles such as oil pumping trucks, oil-well repair trucks, fracking trucks, well flushing-wax removal trucks, and boiler trucks. The company also produce specialized equipment and components for oil well repair and maintenance, fracking, oil well cleaning and wax removal, oil pumping, and boilers.

Share on Social Networks: